Related references
Note: Only part of the references are listed.Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Jian Qiao et al.
NATURE MEDICINE (2008)
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy
Kazuhiko Kurozumi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy
M. Janke et al.
GENE THERAPY (2007)
Clinical safety of a viral vector based prostate cancer vaccine strategy
Philip M. Arlen et al.
JOURNAL OF UROLOGY (2007)
Coadministration of a herpes simplex virus-2-based oncolytic virus and cyclophosphamide produces a synergistic antitumor effect and enhances tumor-specific immune responses
Hongtao Li et al.
CANCER RESEARCH (2007)
Chemotherapy enhances CD8+ T cell-mediated antitumor immunity induced by vaccination with vaccinia virus
Chung Kil Song et al.
MOLECULAR THERAPY (2007)
Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4
Dawn E. Post et al.
CANCER RESEARCH (2007)
Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancer
Dennis Hoffmann et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Local and distant immune-mediated control of colon cancer growth with fusogenic membrane glycoproteins in combination with viral oncolysis
Dennis Hoffmann et al.
HUMAN GENE THERAPY (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model
Hongtao Li et al.
JOURNAL OF GENE MEDICINE (2007)
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration
Laura Bracci et al.
CLINICAL CANCER RESEARCH (2007)
Combining immune cell and viral therapy for the treatment of cancer
S. H. Thorne et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma
Hongtao Li et al.
CLINICAL CANCER RESEARCH (2007)
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8(+) T-cell response to reptide vaccination: Creation of a beneficial host microenvironment involving type IIFNs and myeloid cells
Mohamed L. Salem et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging
Martine L. M. Lamfers et al.
MOLECULAR THERAPY (2006)
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
Jennifer C. C. Hu et al.
CLINICAL CANCER RESEARCH (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF
J. H. Kim et al.
MOLECULAR THERAPY (2006)
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Giulia Fulci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy
Dennis Hoffmann et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect
K-J Choi et al.
GENE THERAPY (2006)
Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control
Guy R. Simpson et al.
CANCER RESEARCH (2006)
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers
S Varghese et al.
CANCER GENE THERAPY (2006)
Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy
F Errington et al.
CLINICAL CANCER RESEARCH (2006)
Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses
NC Di Paolo et al.
CANCER RESEARCH (2006)
Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy
Y Ino et al.
CLINICAL CANCER RESEARCH (2006)
Viral vectors for cancer immunotherapy
R Harrop et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming
F Errington et al.
GENE THERAPY (2006)
Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus
H Kambara et al.
CANCER RESEARCH (2005)
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
LA Emens et al.
CANCER RESEARCH (2005)
Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory
V Schirrmacher
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Fighting cancer with vaccinia virus: Teaching new tricks to an old dog
YQ Shen et al.
MOLECULAR THERAPY (2005)
Clinical applications of recombinant virus-based cancer immunotherapy
M Adamina et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis
H Wakimoto et al.
GENE THERAPY (2004)
Targeted delivery of adenoviral vectors by cytotoxic T cells
P Yotnda et al.
BLOOD (2004)
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
SA Rosenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Destruction of nonimmunogenic mammary tumor cells by a fusogenic oncolytic herpes simplex virus induces potent antitumor immunity
M Nakamori et al.
MOLECULAR THERAPY (2004)
Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect
XP Fu et al.
MOLECULAR THERAPY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Ifosfamide and cyclophosphamide: Effects on immunosurveillance
G Binotto et al.
ONCOLOGY (2003)
Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10△PK
T Gyotoku et al.
VACCINE (2002)
The complement response against an oncolytic virus is species-specific in its activation pathways
H Wakimoto et al.
MOLECULAR THERAPY (2002)
Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model
P Matar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Physiological significance of apoptosis in animal virus infection
AH Koyama et al.
MICROBES AND INFECTION (2000)
HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
A Asea et al.
NATURE MEDICINE (2000)
Share Paper
